UHT UNIVERSAL HEALTH REALTY INCOME TRUST

Overview and Growth

UNIVERSAL HEALTH REALTY INCOME TRUST generated $99.19M of revenue in fiscal 2025, with net income of $17.61M and an operating cash inflow of $49.09M. At $99.19M, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Revenue was 0.2% above fiscal 2024 revenue of $99.01M, marking a year-over-year increase. The company reported diluted EPS of $1.27, adding a shareholder-level measure to the absolute income figures considered below. Against diluted EPS of $1.39 in fiscal 2024, the current result was 8.6% lower. Diluted shares averaged 13.86M; this is the reported share base over which the company’s diluted per-share earnings were spread. Compared with 13.84M diluted shares in fiscal 2024, the current 13.86M base was 0.2% higher. The company employed $564.91M of total assets, the balance-sheet base supporting its current operating and cash-flow results. Revenue equaled 0.18x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

Operating income was $34.76M, the earnings remaining from reported operations after the company’s recognized operating cost structure. Relative to revenue, operating income represented 35.0%, showing how efficiently sales converted into operating profit. After all reported below-operating-line items, the company recorded net income of $17.61M for the fiscal year. Measured against reported revenue, net income produced a 17.8% margin after operating costs and the remaining recognized items. EBITDA was $63.62M, supplying an additional view of reported operating earnings before interest, taxes, depreciation, and amortization. The relationship between net income and period-end equity was 11.6%, indicating the profitability achieved on book capital. Net income represented 3.1% of period-end assets, placing the company’s bottom-line result against the total resource base employed. Against $19.23M in fiscal 2024, the current $17.61M bottom line finished below the prior-year result in absolute terms.

Liquidity and Capital Structure

Total assets were $564.91M, supported by $412.52M of liabilities and $152.38M of shareholder equity. Reported cash and equivalents were $6.69M, separating immediately recognizable cash resources from the rest of the current-asset base. The company carried $374.77M of total debt at period end, which frames its leverage and debt-service burden. Against book equity, debt measured 2.46x, placing the company’s financial leverage in clear balance-sheet terms. The debt-to-assets relationship was 66.3%, comparing borrowing with the total asset balance. Book equity represented 27.0% of total assets, quantifying the balance-sheet share supported by shareholder capital. Relative to total assets, liabilities measured 73.0%, complementing the separate equity-based view of the company’s capital structure. The cash-to-assets relationship was 1.2%, comparing reported cash and equivalents with the full positive asset balance. The asset base changed 2.7% from $580.86M in fiscal 2024, leaving current total assets lower year over year. Book equity was 15.1% lower than fiscal 2024 equity of $179.54M, showing how shareholder capital changed year over year. The reported cash balance changed 5.8% from $7.10M in fiscal 2024, ending lower year over year.

Cash Flow and Earnings Quality

Operating activities produced a cash inflow of $49.09M, giving the cash-flow counterpart to the accrual-based profit measures reported for the year. Against net income, operating cash flow measured 2.79x, showing the relationship between accrual earnings and operating cash. The operating cash outcome moved from $46.91M in fiscal 2024 to $49.09M, ending above the prior-year level.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.